In the latest trading session, fuboTV Inc. (FUBO) closed at $14.65, marking a -0.95% move from the previous day. This change lagged the S&P 500's 0.28% gain on the day. At the same time, the Dow added 0.11%, and the tech-heavy Nasdaq gained 0.14%.Heading into today, shares of the company had lost 11.44% over the past month, lagging the Consumer Discretionary sector's loss of 2.13% and the S&P 500's gain of 0.12% in that time.fuboTV Inc. will be looking to display strength as it nears its next earnings release. In that report, analysts expect fuboTV Inc. to post earnings of -$0.66 per share. This would mark a year-over-year decline of 69.23%. Meanwhile, our latest consensus estimate is calling for revenue of $208.98 million, up 98.88% from the prior-year quarter.Any recent changes to analyst estimates for fuboTV Inc. should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.32% higher. fuboTV Inc. is currently sporting a Zacks Rank of #2 (Buy).The Broadcast Radio and Television industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report fuboTV Inc. (FUBO): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research